Lou Kost, Jr., Cofounder, Acting Chief Executive Officer, President, Secretary and Director, Lou Kost, Jr. is Secretary of Phoenix Biotechnology, Inc. Mr. Kost attended the University of Texas at Austin, and St. Mary's University in San Antonio, Texas, where he studied marketing and financial management. Mr. Kost has been at various times a venture capitalist and management consultant. Mr. Kost is a former Texas state representative who served on the Banking Committee. Mr. Kost is currently a Director and Secretary of Anviram, Inc. Among other duties, Mr. Kost is responsible for interacting with investment bankers and the shareholders of the Company.
Crandell Addington, Cofounder, Chairman, and Director. Mr. Addington is a cum laude graduate from Southwestern University, Georgetown, Texas, majoring in economics and accounting. Mr. Addington received post-graduate education in various sciences at Trinity University, San Antonio, Texas. Mr. Addington has, over the course of 40 years, founded and/or operated successful enterprises ranging from chemical manufacturing to oil and gas exploration, development, and production. Mr. Addington is also President and Chairman of the Board of Anviram, Inc. As a result of his prior and current corporate leadership positions, Mr. Addington has been responsible, among other duties, for interacting with biomedical researchers and clinicians both in the United States and Latin America.
Robert A. Newman, Ph.D., Chief Science Officer, Chairman of the Scientific Advisory Board, and Director. Dr. Newman obtained his M.S. and Ph.D. degrees in Pharmacology and Toxicology from the University of Connecticut and then served in postdoctoral positions at the Medical School of the University of Georgia as well as the Department of Biochemistry at the University of Vermont. He served as a faculty member at the University of Vermont Medical School for seven years and then spent a sabbatical year at Stanford University performing research on immune targeted therapy. He spent 24 years at the University of Texas M. D. Anderson Cancer Center (MDACC) in Houston, Texas where he held the D. B. Lane Distinguished Professorship Chair. At MDACC he served as the founder and Co-Director of the Pharmaceutical Development Center and the institution's Analytical Center. He has published over 320 articles dealing with the preclinical and clinical pharmacology, toxicology and development of therapies for the prevention and treatment of malignant diseases.
Carlos Torres, Chief Information Technology Officer, Mr. Torres holds a Bachelor's degree in Computer Science and Business Administration, and a Master of Science Degree in Management of Technology from the University of Texas at San Antonio. Among other duties, Mr. Torres ensures that IT is an integral component of our business strategy in order to enable, facilitate and proactively generate competitive advantage for top line growth and operational optimization for bottom line performance. Outside of the office, Carlos enjoys spending time with his wife and two children and is also an avid triathlete who has won numerous awards and has represented the United States as part of Team USA.